<![CDATA[Sanofi ]]>enghttp://www.nasdaqomx.comCopyright (c)2014 NASDAQ OMXhttp://blogs.law.harvard.edu/tech/rssNASDAQ OMX - http://www.nasdaqomx.com/onlineservices@nasdaqomx.com (NASDAQ OMX)onlineservices@nasdaqomx.com (NASDAQ OMX)10<![CDATA[Sanofi ]]>http://www.huginonline.com/France/SANOFI/logo.jpghttp://www.huginonline.com450160<![CDATA[Sanofi and Regeneron Announce New Positive Praluent® (alirocumab) Phase 3 Data Presented at ESC Congress 2015]]>Tue, 1 Sep 2015 15:00:00 +0200http://cws.huginonline.com/S/152918/PR/201509/1948976_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201509/1948976_5.htmlhttp://hugin.info/152918/R/1948976/708155.pdf<![CDATA[Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes]]>Mon, 31 Aug 2015 15:06:00 +0200http://cws.huginonline.com/S/152918/PR/201508/1948629_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201508/1948629_5.htmlhttp://hugin.info/152918/R/1948629/707909.pdf<![CDATA[Sanofi, Evotec and Apeiron Biologics Enter Collaboration To Develop Novel Small Molecule Immuno-Oncology Treatments]]>Mon, 10 Aug 2015 07:00:00 +0200http://cws.huginonline.com/S/152918/PR/201508/1944403_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201508/1944403_5.htmlhttp://hugin.info/152918/R/1944403/704431.pdf<![CDATA[Sanofi, Evotec Enter New Research Collaboration to Discover and Develop Novel Diabetes Therapies]]>Fri, 7 Aug 2015 07:00:00 +0200http://cws.huginonline.com/S/152918/PR/201508/1944231_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201508/1944231_5.htmlhttp://hugin.info/152918/R/1944231/704308.pdf<![CDATA[Sanofi : Online Availability of Sanofi Group's Half-Year Financial Report for 2015]]>Fri, 31 Jul 2015 16:14:09 +0200http://cws.huginonline.com/S/152918/PR/201507/1942267_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201507/1942267_5.htmlhttp://hugin.info/152918/R/1942267/702541.pdf<![CDATA[Sanofi delivers solid sales and business EPS(1) growth in Q2 2015]]>Thu, 30 Jul 2015 07:30:00 +0200http://cws.huginonline.com/S/152918/PR/201507/1942150_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201507/1942150_5.htmlhttp://hugin.info/152918/R/1942150/702446.pdf<![CDATA[Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint]]>Wed, 29 Jul 2015 07:00:00 +0200http://cws.huginonline.com/S/152918/PR/201507/1941461_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201507/1941461_5.htmlhttp://hugin.info/152918/R/1941461/701757.pdf<![CDATA[Sanofi and Regeneron Launch Major New Immuno-Oncology Collaboration]]>Tue, 28 Jul 2015 07:00:00 +0200http://cws.huginonline.com/S/152918/PR/201507/1941594_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201507/1941594_5.htmlhttp://hugin.info/152918/R/1941594/701853.pdf<![CDATA[New England Journal of Medicine Publishes New Analyses Confirming that Sanofi Pasteur's Vaccine Candidate Safely Protects Pre-Adolescents to Adults Against Dengue]]>Mon, 27 Jul 2015 18:00:00 +0200http://cws.huginonline.com/S/152918/PR/201507/1940753_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201507/1940753_5.htmlhttp://hugin.info/152918/R/1940753/701006.pdf<![CDATA[Sanofi: Genzyme Strengthens Endocrinology Portfolio with Acquisition of Rare Disease Therapy Caprelsa® (vandetanib) from AstraZeneca]]>Mon, 27 Jul 2015 08:00:00 +0200http://cws.huginonline.com/S/152918/PR/201507/1941265_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201507/1941265_5.htmlhttp://hugin.info/152918/R/1941265/701552.pdf